DE602006011360D1 - Katalysiertes verfahren zur herstellung von c-5-substituierten heterocyclischen inhibitoren von 11beta-hydroxysteroiddehydrogenase vom typ 1 - Google Patents

Katalysiertes verfahren zur herstellung von c-5-substituierten heterocyclischen inhibitoren von 11beta-hydroxysteroiddehydrogenase vom typ 1

Info

Publication number
DE602006011360D1
DE602006011360D1 DE602006011360T DE602006011360T DE602006011360D1 DE 602006011360 D1 DE602006011360 D1 DE 602006011360D1 DE 602006011360 T DE602006011360 T DE 602006011360T DE 602006011360 T DE602006011360 T DE 602006011360T DE 602006011360 D1 DE602006011360 D1 DE 602006011360D1
Authority
DE
Germany
Prior art keywords
hydroxysteroiddehydrogenase
11beta
preparation
type
substituted heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006011360T
Other languages
English (en)
Inventor
Emilio Bunel
Anil Guram
Qingyian Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of DE602006011360D1 publication Critical patent/DE602006011360D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/42Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
DE602006011360T 2005-11-22 2006-11-01 Katalysiertes verfahren zur herstellung von c-5-substituierten heterocyclischen inhibitoren von 11beta-hydroxysteroiddehydrogenase vom typ 1 Active DE602006011360D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73857405P 2005-11-22 2005-11-22
PCT/US2006/042913 WO2007061600A1 (en) 2005-11-22 2006-11-01 CATALYZED PROCESS OF MAKING C-5-SUBSTITUTED HETEROCYCLIC INHIBITORS OF 11ß-HYDROXY STEROID DEHYDROGENASE TYPE 1

Publications (1)

Publication Number Publication Date
DE602006011360D1 true DE602006011360D1 (de) 2010-02-04

Family

ID=37882184

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006011360T Active DE602006011360D1 (de) 2005-11-22 2006-11-01 Katalysiertes verfahren zur herstellung von c-5-substituierten heterocyclischen inhibitoren von 11beta-hydroxysteroiddehydrogenase vom typ 1

Country Status (8)

Country Link
US (1) US7541474B2 (de)
EP (1) EP1951695B1 (de)
AT (1) ATE452881T1 (de)
AU (1) AU2006317070B2 (de)
CA (1) CA2630558A1 (de)
DE (1) DE602006011360D1 (de)
ES (1) ES2335141T3 (de)
WO (1) WO2007061600A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2335141T3 (es) 2005-11-22 2010-03-22 Amgen Inc. Procedimiento catalizado para hacer inhibidores heterociclicos sustituidos en c-5 de la 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.
JP5411850B2 (ja) * 2007-06-21 2014-02-12 アムジエン・インコーポレーテツド 置換2−アミノ−チアゾロンを作製するための方法
ES2386613T3 (es) * 2008-07-29 2012-08-23 Amgen, Inc Procedimiento asimétrico para preparar 2-amino-tiazolonas sustituidas
WO2012051139A1 (en) 2010-10-15 2012-04-19 Amgen Inc. New uses for substituted 2-amino-thiazolones in treating alzheimer's disease
CA3017740A1 (en) 2016-03-16 2017-09-21 Pearlie BURNETTE Small molecules against cereblon to enhance effector t cell function
PE20210184A1 (es) 2018-07-11 2021-02-02 H Lee Moffitt Cancer Ct & Res Compuestos inmunomoduladores dimericos contra mecanismos basados en cereblon
CN108976170B (zh) * 2018-08-14 2022-04-22 华南理工大学 一种5-三氟甲基-4h-咪唑啉-4-酮衍生物及合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE417837T1 (de) * 2004-05-24 2009-01-15 Amgen Inc Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
ES2335141T3 (es) 2005-11-22 2010-03-22 Amgen Inc. Procedimiento catalizado para hacer inhibidores heterociclicos sustituidos en c-5 de la 11-beta-hidroxiesteroide deshidrogenasa de tipo 1.

Also Published As

Publication number Publication date
ES2335141T3 (es) 2010-03-22
US7541474B2 (en) 2009-06-02
AU2006317070A1 (en) 2007-05-31
EP1951695A1 (de) 2008-08-06
US20070117985A1 (en) 2007-05-24
AU2006317070B2 (en) 2011-06-23
ATE452881T1 (de) 2010-01-15
WO2007061600A1 (en) 2007-05-31
EP1951695B1 (de) 2009-12-23
CA2630558A1 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
DE602006011360D1 (de) Katalysiertes verfahren zur herstellung von c-5-substituierten heterocyclischen inhibitoren von 11beta-hydroxysteroiddehydrogenase vom typ 1
DE602006017192D1 (de) Verfahren zur herstellung von oligonukleotiden
ATE510930T1 (de) Zusammensetzungen und verfahren zur bearbeitung und amplifikation von dna mit verwendung mehrerer enzyme in einer einzigen reaktion
WO2007134086A3 (en) Methods of treating fatty liver disease comprising inhibiting glucosphingolipid synthesis
DE502007005386D1 (de) Verfahren zur Herstellung von Di- und Polyaminen der Diphenylmethanreihe
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE517190T1 (de) Verfahren zur fermentativen herstellung von 1,5- diaminopentan
ATE486844T1 (de) Verfahren zur herstellung von adipodinitril durch hydrocyanierung von 1,3-butadien
ATE430480T1 (de) Verfahren zur herstellung von nährmittelzusammensetzungen
DE602005017027D1 (de) Verfahren zur enzymatischen herstellung von (s)-3-cyano-5-methylhexansäure
DE502005011299D1 (de) Verfahren zur herstellung von linearem pentennitril
ATE462012T1 (de) Ezymatisches verfahren zur herstellung von 2-o- glyceryl-alpha-d-glucopyranosid
DE502005001841D1 (de) Verfahren zur herstellung von 1,4-diphenylazetidinon-derivaten
ATE537706T1 (de) Antimikrobielles säuerndes futtermittel und verfahren zu seiner herstellung
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
DE502005000428D1 (de) Verfahren zur Herstellung von 1,2-Diaminocyclohexan-Platin(II)-Komplexen
ATE488597T1 (de) Verfahren zur herstellung optisch aktiver aminosäuren unter verwendung eines ganzzellenkatalysators
DE602005021110D1 (de) Verfahren zur herstellung von n-piperidino-1,5-diphenylpyrazol-3-carboxamid-derivaten
ATE410409T1 (de) Verfahren zur herstellung von gesättigten nitrilen
DE502006003143D1 (de) Verbessertes verfahren zur herstellung von ramipril
DE502005007702D1 (de) Verfahren zur herstellung von terrylen-3,4:11,12-t
ATE503767T1 (de) Herstellung eines von willenbrand faktor- präparates mit hoher spezifischer aktivität
ATE378312T1 (de) Verfahren zur herstellung von adapalene
ATE482188T1 (de) Verfahren zur synthese von 3-hydroxyglutaronitril
ATE465152T1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition